go-v.orgdoi

Mesenchymal chondrosarcoma - a therapeutic challenge

Lea Galunić Bilić, Zdenko Krajina, Antonio Juretić, Vanja Dekleva, Kresimir Loncar, Lana Jajac Bručić, Ana Mišir Krpan, Fedor Šantek, Martina Bašić-Koretić · Paediatria Croatica · 2013

  • DOI 10.13112/pc.700
  • Publisher Children's Diseases Zagreb
  • Type article
  • Issued 2013

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Paediatria Croatica · Children's Diseases Zagreb · article · 2013

Abstract

Mesenchymal chondrosarcoma is an aggressive subtype of chondrosarcoma that accounts for less than 1% of all sarcomas. Although it appears in all age groups, it is more frequent in younger patients. In view of its low incidence, there is no consensus about its optimal treatment. The aim of this presentation is to share our experience of treating a patient suffering from mesenchymal chondrosarcoma. A 46-year-old female patient suffered for several years from health problems in the form of undefined pain and pressure in the right occipital region and later in the form of right-sided deafness.

Magnetic resonance imaging showed an extracranial tumor mass spreading through the occipital bone into the neighboring brain tissue. An operation was performed and the tumor was removed. Histopathologic examination demonstrated mesenchymal chondrosarcoma. Follow up MRI revealed tumor relapse and a second operation was performed. Histopathology confirmed mesenchymal chondrosarcoma. As adjuvant therapy, 3D-CRT treatment using a tumor dose of 56 Gy in 28 fractions was administered. Afterwards, the patient was regularly followed up.

Postoperative follow up using positron emission tomography/computed tomography (PET/CT) disclosed pathologic accumulation of fluorine-18-deoxyglucose (FDG) in the neck lymph nodes and lung parenchymal tissue. Ultrasound guided fine needle aspiration of the suspect neck lymph nodes was performed but only inflammatory cells and no tumor cells were found. With regard to the suspect FDG accumulation in the lung tissue, a thoracic surgeon was consulted. He suggested regular follow up of the patient. Mesenchymal chondrosarcoma is a relatively rare tumor with a high tendency towards local aggressive growth and distant metastases.

As regards the presented case, adjuvant radiotherapy with regular follow up appointments seems to be an advisable and rational option. The question that remains is: which chemotherapy option should be administered and when in the treatment of this rare type of tumor?

Open the resolved locator · 10.13112/pc.700

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 03:55 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
http://dx.doi.org/10.13112/pc.700
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.